Effectiveness of the Cognitive Orientation to Daily Occupational Performance (CO-OP)
Launched by LOUISE MØLDRUP NIELSEN · Apr 4, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special approach called the Cognitive Orientation to daily Occupational Performance (CO-OP) to see how well it helps adults over 45 years old who have had a stroke or a brain injury. The main goal is to find out if this method can improve their ability to carry out daily activities and enhance their quality of life compared to standard rehabilitation practices. Participants will learn how to set goals based on what matters most to them, receive personalized education and training, and practice skills with the support of therapists.
To be eligible for this trial, participants must have had a stroke or a traumatic brain injury, be transitioning from a hospital to community rehabilitation, and have at least one difficulty with daily activities. Those with conditions like dementia or drug abuse, or who do not speak or understand Danish, will not be included. If you or a loved one join the study, you can expect structured sessions focusing on problem-solving and skill development, as well as some homework to reinforce what you've learned. The trial aims to provide deeper insights into how this innovative approach can aid recovery in a real-world rehabilitation setting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke or traumatic brain injury
- • Reffered from acute hospital or specialized rehabilitation units to municipal rehabilitation
- • Having at least on ADL performance issue
- Exclusion Criteria:
- • Dementia, Psychotic diagnoses, commotio, Brain tumor or degenerative neurological conditions.
- • Alkohol or drug abuse
- • Not speeking or understanding Danish
About Louise Møldrup Nielsen
Louise Møldrup Nielsen is a dedicated clinical trial sponsor renowned for her commitment to advancing medical research and enhancing patient care. With a robust background in clinical operations and regulatory affairs, she leads initiatives that emphasize innovation, ethical standards, and patient safety. Her expertise facilitates the efficient design and execution of clinical trials, ensuring compliance with industry regulations and fostering collaborations that drive scientific discovery. Through her leadership, she aims to bridge the gap between research and real-world application, ultimately contributing to the development of effective therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Skive, , Denmark
Viborg, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported